54 completed, 17 recruiting, 16 unknown, 12 not yet recruiting. 115 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 115 | Completed 54, Recruiting 17, Unknown 16, Not yet recruiting 12, Terminated 7, Withdrawn 6, Active not recruiting 2, Enrolling by invitation 1 |
Follow Therapeutics: new trials by email Literature Review of Therapeutics trials Research Report on Therapeutics
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Sucrosomial Vs Intravenous Iron for Preoperative Anemia Treatment with oral sucrosomial iron, Treatment with intravenous iron - Anemia, Iron Deficiency Anemia | Phase 4 | Withdrawn | University of Rochester | 2026-12-01 | 2026-10-06 | |
| Evaluating Treatment Outcomes Using Darolutamide and Androgen Deprivation Therapy in Patients With Metastatic Hormone-Sensitive Prostate Cancer. Darolutamide, Physician choice Androgen Deprivation (Hormone) Therapy - Prostate Cancer | Phase 4 | Not yet recruiting | University of Chicago | 80 | 2026-11-01 | 2026-01-08 |
| Metabolic Surgery for Atrial Fibrillation Elimination Roux-en-Y Gastric Bypass or Sleeve Gastrectomy, Anti-Obesity Medication (AOM) treatment - Atrial Fibrillation, Obesity and Obesity-related Medical Conditions | Phase 4 | Not yet recruiting | Ali Aminian | 100 | 2026-11-01 | 2026-04-17 |
| Central Apnea in Heart Failure: Physiological Mechanisms to Inform Treatment Trazodone + positive airway pressure (PAP) therapy, Oxygen + positive airway pressure (PAP) therapy - Sleep Disordered Breathing, Able Bodied | Phase 4 | Recruiting | VA Office of Research and Development | 200 | 2026-09-16 | 2026-10-13 |
| Individualized Multiplex Pathophysiological Treatment of Severe Acute Infections: N-Acetylcysteine N-Acetylcysteine (NAC) Treatment - Sepsis, Acute Infection | Phase 4 | Recruiting | Theis S. Itenov | 360 | 2026-09-07 | 2026-09-16 |
| A Comparative Effectiveness Study of Positive Airway Pressure (PAP) Therapy, Dental Device, and Atomoxetine-Oxybutynin for Treatment of Obstructive Sleep Apnea in Adults Positive airway pressure (PAP) therapy, Sleep dental device, Atomoxetine-oxybutynin - Obstructive Sleep Apnea (OSA) | Phase 4 | Recruiting | Sairam Parthasarathy | 2400 | 2026-09-04 | 2026-10-19 |
| Dymista in Chinese Adolescents Treatment with 137 µg azelastine hydrochloride and 50 μg of fluticasone propionate - Allergic Rhinitis Due to Allergens | Phase 4 | Completed | Viatris Inc. | 100 | 2026-05-08 | 2026-11-03 |
| Comparative Effectiveness of Alginate, Magaldrate, Sucralfate, Proton Pump Inhibitors, and Diet in Laryngopharyngeal Reflux Disease Alginate, Magaldrate, Sucralfate - Laryngopharyngeal Reflux Disease | Phase 4 | Not yet recruiting | University of Mons | 800 | 2026-05-01 | 2026-05-28 |
| Assessing Residual Inflammation and Macrophage Presence in Lupus Nephritis After 3 Months of Intensified Treatment With Prednisolone, Mycofenolate Mofetil and Voclosporin as Compared to Mycofenolate Mofetil and Prednisolone Kidney Biopsy, Voclosporin (LUPKYNIS), Blood, feces and urine sample collection - Lupus Nephritis, Systemic Lupus Erythematosus (SLE) | Phase 4 | Recruiting | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 55 | 2026-04-23 | 2026-08-12 |
| Effects of Recombinant Human Growth Hormone in Elderly Patients With Moderate to Severe Acute Brain Injury (GH-ABI-RCT) Recombinant Human Growth Hormone (rhGH) Injection, Standard Care (Treatment as Usual) - Acute Brain Injuries, Moderate to Severe Traumatic Brain Injury | Phase 4 | Not yet recruiting | Anhui Provincial Hospital | 160 | 2026-04-10 | 2026-03-19 |
| Doxycycline Prophylaxis for Prevention of Sexually Transmitted Infections Doxycycline hyclate delayed released 200 mg, Doxycycline hyclate delayed released 200 mg weekly, Per standard of care with quarterly STI testing/treatment and sexual health counseling - Gonorrhea, Chlamydia | Phase 4 | Recruiting | Westat | 760 | 2026-02-27 | 2026-10-16 |
| Effect of Tirzepatide on Cardiovascular and Metabolic Parameters in Obese Adult Patients With Congenital Heart Disease Treatment with tirzapatide, Treatment with placebo - Obesity & Overweight, Adult Congenital Heart Disease | Phase 4 | Not yet recruiting | University Medical Centre Ljubljana | 30 | 2026-01-20 | 2026-01-21 |
| Comparative Efficacy of 100-, 200-, & 400-mg Amiodarone in Patients With Paroxysmal AF Depending on Plasma Concentration Pharmacotherapy with amiodarone 200 mg per day, Treatment with Amiodarone at a dose 100 mg per day, Treatment with Amiodarone at a dose 400 mg per day - Paroxysmal AF, Treatment Decisions | Phase 4 | Enrolling by invitation | Tomsk National Research Medical Center of the Russian Academy of Sciences | 80 | 2026-01-12 | 2026-03-23 |
| A Prospective, Randomized, Controlled Study Comparing the Efficacy of Intranasal Corticosteroids (INCS) Combined With Intranasal Antihistamines (INAH) and INCS Combined With Oral Antihistamines (OAH) in the Treatment of Moderate to Severe Allergic Rhinitis Symptoms Intranasal corticosteroids (INCS) combined with oral antihistamines (OAH) used for treatment, Intranasal corticosteroids (INCS) combined with nasal antihistamines (INAH) used for treatment. - Allergic Rhinitis | Phase 4 | Not yet recruiting | China-Japan Union Hospital | 50 | 2026-01-01 | 2025-12-19 |
| SGLT2 Inhibitors on Coronary Atherosclerosis Progression Via Perivascular Adipose Tissue in Diabetes Dapagliflozin (DAPA), Standard Care (Treatment as Usual) - Type 2 Diabetes Mellitus (T2DM), Coronary Artery Disease | Phase 4 | Recruiting | Junjie Yang | 144 | 2026-01-01 | 2026-05-29 |
| Effects of Henagliflozin Proline and Metformin XR on Body Composition in Geriatric Patients With Newly Diagnosed T2DM Henagliflozin Proline Tablets treatment, Metformin XR treatment - Diabetes Type 2 | Phase 4 | Not yet recruiting | Bin Lu | 116 | 2025-12-30 | 2026-01-07 |
| Prasugrel Monotherapy Reduced Dose in Acute and Chronic Coronary Syndrome Patients After Percutaneous Coronary Intervention (PROMOTE) Prasugrel 5 mg, Dual Antiplatelet (DAPT) Therapy - Coronary Arterial Disease (CAD), Percutaneous Coronary Intervention (PCI) | Phase 4 | Recruiting | J.P.S Henriques | 300 | 2025-11-13 | 2026-03-04 |
| COMS for Chronic Ulcers Treatment Concurrent optical and magnetic stimulation (COMS) treatment - Venous Leg Ulcer, Wound Heal | Phase 4 | Recruiting | Sebastian Probst | 122 | 2025-10-01 | 2026-05-08 |
| Rivaroxaban for Slow Coronary Flow After PCI in STEMI Dual Antiplatelet (DAPT) Therapy, Rivaroxaban - ST Elevation Myocardial Infarction, No-Reflow Phenomenon | Phase 4 | Not yet recruiting | Second Affiliated Hospital, Zhejiang University, School of Medicine | 60 | 2025-10-01 | 2025-09-29 |
| Algorithm Guided Treatment Versus Treatment as Usual (TAU) for Patients With Treatment Resistant Depression Algorithm guided treatment (AGT), Treatment as usual (TAU) - Treatment Resistant Depression (TRD) | Phase 4 | Recruiting | Aalborg University Hospital | 80 | 2025-08-13 | 2026-04-27 |
Showing 20 of 115. Sign in to see all of them.
Schizophrenia (7) · Psychotic Disorders (6) · Diabetes Mellitus, Type 2 (5) · Pain, Postoperative (5) · Atrial Fibrillation (4) · Infections (4) · Substance-Related Disorders (4) · Coronary Artery Disease (3) · Depression (3) · Glaucoma (3) · Hemorrhage (3) · Liver Diseases (3) · Rhinitis, Allergic (3) · Albuminuria (2) · Alcoholism (2)
Aristotle University Of Thessaloniki (3) · Asan Medical Center (2) · Assistance Publique - Hôpitaux de Paris (2) · Copenhagen University Hospital, Rigshospitalet (2) · Cyberonics, Inc. (2) · Heron Therapeutics (2) · National Institute of Cardiology, Warsaw, Poland (2) · University Hospital, Bordeaux (2) · University Hospital, Ghent (2) · Aalborg University Hospital (1) · Abbott Medical Devices (1) · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (1) · Aditi Chadha (1) · Ali Aminian (1) · Anders Rane, MD, PhD, Senior professor (1)
United States (27) · China (10) · France (9) · Canada (8) · Germany (8) · Spain (8) · Denmark (7) · United Kingdom (6) · Belgium (5) · South Korea (5) · India (4) · Netherlands (4) · Austria (3) · Poland (3) · Sweden (3)
Anastasios G Konstas, MD, PhD (2) · Radoslaw Pracon, MD PhD (2) · Alan Green, MD (1) · Alberto Alonso, MD (1) · Ali Aminani (1) · Anastasios Konstas, MD, phD (1) · Anders Rane, Prof. MD (1) · Andreea Ciudin (1) · Bertille de Barbeyrac, MD (1) · Bonaventura Clotet, MD,PhD (1) · Brian J Lipworth, MD (1) · Bryan Dechairo, PhD (1) · Byung-Wook Kim, MD, PhD (1)
PMID 11350323, PMID 15824508, PMID 18285392, PMID 19212970, PMID 19829198, PMID 20146834, PMID 20483968, PMID 20500877, PMID 21367351, PMID 21464362, PMID 21762829, PMID 21854593, PMID 21960068, PMID 21999413, PMID 22152230, PMID 22192967, PMID 22304968, PMID 22404963, PMID 23162393, PMID 23184657, PMID 23204039, PMID 23225338, PMID 23290323, PMID 23332608, PMID 23351813, PMID 23370069, PMID 23377641, PMID 23407203, PMID 23496375, PMID 23580378, PMID 23608160, PMID 23729989, PMID 23750465, PMID 23801589, PMID 23878437, PMID 23886736, PMID 24338947, PMID 24421044, PMID 24619599, PMID 24660674, PMID 24754318, PMID 25272965, PMID 25529851, PMID 25562579, PMID 25637520, PMID 26220080, PMID 26390920, PMID 26563229, PMID 26670630, PMID 26681191
2004 (1), 2015 (1), 2023 (1), 2025 (1), I01RD001576 (1), R01DA013196 (1), R01DA016764 (1), R01MH084900 (1), R01MH120317 (1), U01MH057858 (1), UM2HD111076 (1), UM2HD111102 (1)